New eczema treatment begins human testing
NCT ID NCT07235384
Summary
This early-stage study is testing a new drug called ZL-1503 for moderate-to-severe eczema (atopic dermatitis). Researchers will first give single doses to healthy volunteers to check safety, then give multiple doses to people with eczema to see how the body processes the drug and if it causes side effects. The main goal is to determine if the drug is safe enough for further testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ZaiLab Site 18001
RECRUITINGAuckland, Auckland, New Zealand
Conditions
Explore the condition pages connected to this study.